These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22554675)

  • 81. Growth potential of aortic autografts and allografts: effects of cryopreservation and immunosuppression in an experimental model.
    Kreitmann B; Riberi A; Zeranska M; Novakovitch G; Metras D
    Eur J Cardiothorac Surg; 1997 May; 11(5):943-52. PubMed ID: 9196313
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Early innate immune events induced by prolonged cold ischemia exacerbate allograft vasculopathy.
    Devitt JJ; King CL; Lee TD; Hancock Friesen CL
    J Cardiothorac Surg; 2011 Jan; 6():2. PubMed ID: 21211039
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Complement independent antibody-mediated endarteritis and transplant arteriopathy in mice.
    Hirohashi T; Uehara S; Chase CM; DellaPelle P; Madsen JC; Russell PS; Colvin RB
    Am J Transplant; 2010 Mar; 10(3):510-7. PubMed ID: 20055805
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Transient immunosuppressive treatment leads to long-term retention of allogeneic myoblasts in hybrid myofibers.
    Pavlath GK; Rando TA; Blau HM
    J Cell Biol; 1994 Dec; 127(6 Pt 2):1923-32. PubMed ID: 7806570
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Role of anti-vimentin antibodies in allograft rejection.
    Rose ML
    Hum Immunol; 2013 Nov; 74(11):1459-62. PubMed ID: 23777935
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Nonvascularized human skin chronic allograft rejection.
    Rotman S; Koch N; Wiesner L; Aubert V; Rosales IA; Colvin RB; Raffoul W; Pascual M
    Am J Transplant; 2019 Nov; 19(11):3191-3196. PubMed ID: 31344327
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The role of B cells in solid organ transplantation.
    Kwun J; Bulut P; Kim E; Dar W; Oh B; Ruhil R; Iwakoshi N; Knechtle SJ
    Semin Immunol; 2012 Apr; 24(2):96-108. PubMed ID: 22137187
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Recent advances in allograft vasculopathy.
    Merola J; Jane-Wit DD; Pober JS
    Curr Opin Organ Transplant; 2017 Feb; 22(1):1-7. PubMed ID: 27898462
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Synergistic effect of alloantibodies or F(ab')2 and prednisone on murine split heart allograft survival.
    Schilling W; Svehag SE
    Acta Pathol Microbiol Scand C; 1976 Aug; 84(4):325-32. PubMed ID: 785946
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Sodium Sulfite Exacerbates Allograft Vasculopathy and Affects Tryptophan Breakdown in Murine Heterotopic Aortic Transplantation.
    Sucher R; Hautz T; Mohr E; Mackowitz M; Mellitzer V; Steger C; Cardini B; Resch T; Margreiter C; Schneeberger S; Brandacher G; Fuchs D; Oberhuber R; Gostner JM
    Oxid Med Cell Longev; 2019; 2019():8461048. PubMed ID: 31089419
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Chronic allograft vasculopathy: new strategies for drug development.
    Häyry P
    Transplant Proc; 1998 Dec; 30(8):3989-90. PubMed ID: 9865271
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Graft vascular disease: immune response meets the vessel wall.
    Mitchell RN
    Annu Rev Pathol; 2009; 4():19-47. PubMed ID: 18717641
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Next-generation pathology detection of T cell-antigen-presenting cell immune synapses in human liver allografts.
    Wood-Trageser MA; Lesniak D; Gambella A; Golnoski K; Feng S; Bucuvalas J; Sanchez-Fueyo A; Demetris AJ
    Hepatology; 2023 Feb; 77(2):355-366. PubMed ID: 35819312
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Differences in alloimmune response between elderly and young mice.
    Book BK; Volz MA; Ward EK; Eckert GJ; Pescovitz MD; Wiebke EA
    Transplant Proc; 2013 Jun; 45(5):1838-41. PubMed ID: 23769054
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The specificity of immunosuppression by alloantibody in the mouse.
    Milton JD
    Transplantation; 1976 Nov; 22(5):445-8. PubMed ID: 996928
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Anti-CD20 Antibody and Calcineurin Inhibitor Combination Therapy Effectively Suppresses Antibody-Mediated Rejection in Murine Orthotopic Lung Transplantation.
    Matsumoto H; Suzuki H; Yamanaka T; Kaiho T; Hata A; Inage T; Ito T; Kamata T; Tanaka K; Sakairi Y; Motohashi S; Yoshino I
    Life (Basel); 2023 Oct; 13(10):. PubMed ID: 37895424
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Humoral immune responses in murine pregnancy. I. Anti-paternal alloantibody levels in maternal serum.
    Bell SC; Billington WD
    J Reprod Immunol; 1981 May; 3(1):3-13. PubMed ID: 7230141
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Evidence that only donor cells produce antibody in a lethally irradiated cell transfer recipient.
    Francus T; Siskind GW
    J Immunol Methods; 1982 Sep; 53(3):345-54. PubMed ID: 7142713
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Response by Wong et al to Letter Regarding Article, "Importance of Routine Antihuman/Leukocyte Antibody Monitoring: De Novo Donor Specific Antibodies Are Associated With Rejection and Allograft Vasculopathy After Heart Transplantation".
    Wong KL; Smith BH; Kremers WK; Pereira NL
    Circulation; 2018 Apr; 137(17):1872-1873. PubMed ID: 29685937
    [No Abstract]   [Full Text] [Related]  

  • 100. Letter by Clerkin et al Regarding Article, "Importance of Routine Antihuman/Leukocyte Antibody Monitoring: De Novo Donor Specific Antibodies Are Associated With Rejection and Allograft Vasculopathy After Heart Transplantation".
    Clerkin KJ; Farr MA; Mancini DM
    Circulation; 2018 Apr; 137(17):1870-1871. PubMed ID: 29685936
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.